Antioxidant Enzyme Deficiency and Oxidative Stress in Asthma: Implications for Therapeutic Antioxidant Strategies
Ali abdalla Hindi 1*, Zeyad Swadi Obaid AL-isawi 2, Sameem S. M. Baker 3
Microbial Bioactives 7(1) 1-6 https://doi.org/10.25163/microbbioacts.7110104
Submitted: 01 August 2024 Revised: 16 September 2024 Published: 17 September 2024
Abstract
Background: Asthma is a chronic inflammatory disorder characterized by oxidative stress, resulting from an imbalance between reactive oxygen species (ROS) and antioxidant defenses. ey oxidative stress markers, including superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), and malondialdehyde (MDA), provide insights into the pathophysiology of asthma. This study aimed to evaluate oxidative stress markers in asthmatic patients by measuring antioxidant enzyme levels and lipid peroxidation products. Methods: A case-control study was conducted at Alsader Medical City in Najaf, involving 87 asthmatic patients (46 males, 41 females) and 33 healthy controls matched by age and sex. Blood samples were collected, and serum levels of SOD, CAT, GST, and MDA were measured using standardized biochemical assays. Statistical analysis was performed to assess group differences and gender-based variations, with a significance level of p<0.05p < 0.05p<0.05. Results: Asthmatic patients exhibited significantly lower SOD (44.1–89.38 U/L vs. 74–94.5 U/L, p<0.001p < 0.001p<0.001), CAT (0.015–0.106 km/min vs. 0.036–0.12 km/min, p<0.001p < 0.001p<0.001), and GST (3.1–18.7 U/L vs. 5.9–19 U/L, p<0.05p < 0.05p<0.05) levels compared to controls. In contrast, MDA levels were markedly elevated (2.2–13.46 µM vs. 0.63–6.59 µM, p<0.001p < 0.001p<0.001), indicating heightened oxidative stress. Gender-based comparisons among asthmatic patients revealed no significant differences in oxidative stress markers between males and females, suggesting a uniform impact of oxidative stress irrespective of sex. Conclusion: The findings highlight a significant oxidative imbalance in asthmatic patients, characterized by reduced antioxidant enzyme activities and elevated lipid peroxidation. These results underscore the role of oxidative stress in asthma pathogenesis and suggest that antioxidant-based therapeutic strategies could mitigate disease severity. Further research is needed to explore personalized approaches to managing oxidative stress in asthma.
Keywords: Asthma, Oxidative stress, Antioxidant enzymes, Malondialdehyde (MDA), Biomarker analysis
References
Aebi, H. (1974). Methods of enzymatic analysis. New York: Academic Press.
Comhair, S. A. A., et al. (2005). Superoxide dismutase inactivation in asthmatic airway remodeling. American Journal of Pathology, 166, 663–666.
Comhair, S. A., Xu, W., Ghosh, S., Thunnissen, F. B., Almasan, A., Calhoun, W. J., Janocha, A. J., Zheng, I., Hazen, S. I., & Erzurum, S. C. (2005). Superoxide dismutase inactivation in the pathophysiology of asthmatic airway remodeling and reactivity. American Journal of Pathology, 166(3), 663–673.
Granic, P. (2001). Oxidative stress diagnostics procedures. Zagreb: Medicinska Naklada.
Habig, W. H., Pabst, M. J., & Jakoby, W. B. (1974). Glutathione S-transferase: The first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry, 249(22), 7130–7139.
Halliwell, B., & Gutteridge, J. M. C. (1989). Free radicals in biology and medicine. Oxford: Clarendon Press.
Halliwell, B., & Gutteridge, J. M. C. (1989). Free radicals in biology and medicine (2nd ed.). Oxford: Clarendon Press.
MacPherson, J. C., Comhair, S. A., Erzurum, S. C., Klein, D. F., Lipscomb, M. F., Kavuru, M. S., Samoszuk, M. K., & Hazen, S. L. (2001). Eosinophils as a major source of nitric oxide-derived oxidants in severe asthma. Journal of Immunology, 166(10), 5763–5772.
MacPherson, J. C., et al. (2001). Eosinophils as a major source of nitric oxide-derived oxidants in severe asthma. Journal of Immunology, 166, 5763–5772.
Mohan, I. K., & Das, U. N. (1997). Oxidant stress and antioxidants in asthma. Medical Science Research, 25, 307–309.
Mohan, I. K., & Das, U. N. (1997). Oxidant stress, antioxidants, nitric oxide, and essential fatty acids in bronchial asthma. Medical Science Research, 25(6), 307–309.
Ozarus, R., et al. (2000). Changes in malondialdehyde levels in asthma with inhaled steroids. Respirology, 5, 289–292.
Ozarus, R., Tahan, V., Turkmen, S., et al. (2000). Changes in malondialdehyde levels in bronchoalveolar fluid and serum by the treatment of asthma with inhaled steroid and beta2-agonist. Respirology, 5(4), 289–292.
Powell, C. V. E., et al. (1994). Antioxidant status in asthma. Pediatric Pulmonology, 18, 34–38.
Rahman, I., Morrison, D., Donaldson, K., & MacNee, W. (1996). Systemic oxidative stress in asthma, COPD, and smokers. American Journal of Respiratory and Critical Care Medicine, 154(4), 1055–1060.
Scanlon, V. C., & Sanders, T. (2007). Essentials of anatomy and physiology (5th ed.). F.A. Davis Company.
Smith, L. J., et al. (1997). Reduced superoxide dismutase in lung cells of asthma patients. Free Radical Biology and Medicine, 22, 1301–1307.
Wood, L. G., et al. (2003). Biomarkers of lipid peroxidation in asthma. European Respiratory Journal, 21, 177–186.
Wood, L. G., Gibson, P. G., & Garg, M. L. (2003). Biomarkers of lipid peroxidation, airway inflammation, and asthma. European Respiratory Journal, 21(2), 177–186.
View Dimensions
View Altmetric
Save
Citation
View
Share